ELV dividend history

AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICRs) of "a+" (Excellent) of the core Blue Cross Blue Shield (BCBS)-branded insurance subsidiaries of Elevance Health, Inc. (Elevance) (Indianapolis, IN) (NYSE:ELV), as well as most of its non-Blue-branded subsidiaries. In addition, AM Best has upgraded the FSR to A (Excellent) from A- (Excellent) and the Long-Term ICR to "a+" (Excellent) from "a-" (Excellent) of Wellpoint Life and Health Insurance Company and Wellpoint West Virginia, Inc. These companies collectively are referred to as Anthem Health. At the same time, AM Best has affirmed the Long-Term ICR of "bbb+"

AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICRs) of "a+" (Excellent) of the core Blue Cross Blue Shield (BCBS)-branded insurance subsidiaries of Elevance Health, Inc. (Elevance) (Indianapolis, IN) (NYSE:ELV), as well as its life insurance subsidiaries. These companies collectively are referred to as Anthem Health. At the same time, AM Best has affirmed the Long-Term ICR of "bbb+" (Good), the Long- and Short-Term Issue Credit Ratings (Long-Term IR; Short-Term IR) of Elevance and the Long-Term IR on the existing surplus notes of Anthem Insurance Companies, Inc. (Indianapolis, IN). In addition, AM Best has affi

Collaboration will leverage the strengths of three care provider entities that will come together to deliver value to consumers and employers across the healthcare journey Elevance Health, Inc. (NYSE:ELV) and Clayton, Dubilier & Rice (CD&R) announced an agreement to form a strategic partnership to accelerate innovation in primary care delivery, enhance the healthcare experience, and improve health outcomes. This effort, which will operate across multiple regions of the United States, will bring together certain care delivery and enablement assets of Elevance Health's Carelon Health and CD&R portfolio companies, apree health and Millennium Physician Group (MPG). "CD&R's collaboration wit

The JUST 100 is the only ranking that recognizes American corporate leadership on business issues prioritized by the public. Today JUST Capital along with CNBC released its annual JUST 100 list as part of its 2024 Rankings of America's Most JUST Companies. Elevance Health (NYSE:ELV) ranked #8 overall and was recognized for the 6th consecutive year for its commitment to serving its workers, customers, communities, the environment, and shareholders. The JUST 100 are determined by scoring performance across a full range social impact and sustainability criteria and comparing companies head-to-head. The rankings measure how the nation's largest corporations are performing on the business is

Advances whole health by strengthening Elevance Health's capabilities in multi-site infusion services, specialty pharmacy Elevance Health (NYSE:ELV) today announced that it has entered into an agreement to acquire Paragon Healthcare, Inc., a company specializing in life-saving and life-giving infusible and injectable therapies. For more than 20 years, Paragon Healthcare has provided infusion services to patients through its omnichannel model of ambulatory infusion centers, home infusion pharmacies, and other specialty pharmacy services. The company, headquartered in Plano, Texas, provides high quality and convenient care to patients with a broad range of chronic and acute conditions.

AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICRs) of "a+" (Excellent) of the core Blue Cross Blue Shield-branded insurance subsidiaries of Elevance Health, Inc. (Elevance) (Indianapolis, IN) (NYSE:ELV), as well as its life insurance subsidiaries. These companies collectively are referred to as Anthem Health. At the same time, AM Best has affirmed the Long-Term ICR of "bbb+" (Good), the Long- and Short-Term Issue Credit Ratings (Long-Term IR; Short-Term IR) of Elevance and the Long-Term IR on the existing surplus notes of Anthem Insurance Companies, Inc. (Indianapolis, IN). Concurrently, AM Best has affirmed t

AM Best has affirmed the Financial Strength Rating (FSR) of A- (Excellent) and a Long-Term Issuer Credit Rating (Long-Term ICR) of "a-" (Excellent) of WellPoint Insurance Services, Inc. (WISI) (Honolulu, HI). The outlook for these Credit Ratings (ratings) is stable. The ratings reflect WISI's balance sheet strength, which AM Best assesses as adequate, as well as its adequate operating performance, limited business profile and appropriate enterprise risk management. In addition, the ratings take into account the support provided by WISI's parent, Elevance Health, Inc. (Elevance Health) (NYSE:ELV). WISI's risk-adjusted capitalization, as measured by Best Capital Adequacy Ratio (BCAR), impro

Elevance Health, Inc. (NYSE:ELV) announced today that for the six-month interest period commencing on October 15, 2022, its 2.750% Senior Convertible Debentures due 2042 (the "Debentures") will accrue contingent interest at a rate of 0.50% per annum of the average trading price of a Debenture for the ten consecutive trading days ended October 14, 2022. Contingent interest, which the Company has determined to be approximately $16.8123 per Note, will be payable on April 15, 2023 to holders of the Debentures as of the April 1, 2023 record date. About Elevance Health, Inc. Elevance Health is a lifetime, trusted health partner fueled by its purpose to improve the health of humanity. The compan

Elevance Health, Inc. (NYSE:ELV) and Blue Cross and Blue Shield of Louisiana announced today that the companies have entered into a definitive agreement through which Elevance Health agrees to acquire Blue Cross and Blue Shield of Louisiana (BCBSLA). BCBSLA will join Elevance Health's affiliated Anthem Blue Cross Blue Shield family of brands. This acquisition will unite two organizations deeply rooted in the communities they serve and aligned in a mission to improve whole health. Together they will continue to prioritize what is best for Louisiana's members and customers by improving access, quality, affordability, and the experience that Louisianians have trusted for almost 90 years. The

AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Rating (Long-Term ICR) of "a+" (Excellent) of the core Blue Cross Blue Shield-branded insurance subsidiaries of Elevance Health, Inc. (Elevance) (Indianapolis, IN) (NYSE:ELV), as well as its branded life insurance subsidiaries. All companies listed above are collectively referred to as Anthem Health. At the same time, AM Best has affirmed the Long-Term ICR of "bbb+" (Good), the Long- and Short-Term Issue Credit Ratings (Long-Term IR; Short-Term IR) of Elevance and the Long-Term IR on the existing surplus notes of Anthem Insurance Companies, Inc. (Indianapolis, IN). Concurrently, AM Bes

Acquisition deepens Elevance Health's capabilities in specialty pharmacy Elevance Health (NYSE:ELV) today announced that it has entered into an agreement with CarepathRx, a portfolio company of Nautic Partners, to acquire BioPlus, a comprehensive specialty pharmacy. BioPlus provides a complete range of specialty pharmacy services for patients living with complex and chronic conditions, such as cancer, multiple sclerosis, hepatitis C, autoimmune diseases, and rheumatology. This acquisition will help Elevance Health meet the specialty drug needs of its clients and customers with a whole-health approach, supported by integrated programs across Elevance Health and Carelon, Elevance Health's he

Elevance Health's affiliated Medicare Advantage plans achieved an overall 4 out of 5 Star rating. Elevance Health, Inc. (NYSE:ELV) announced today that its 2023 affiliated Medicare Advantage plans have earned an overall quality rating of 4 out of 5 Stars from the Centers for Medicare & Medicaid Services (CMS). Many of Elevance Health's affiliated Medicare Advantage plans retained strong ratings of 4, 4.5 and 5 Stars, and 64 percent of consumers in Elevance Health affiliated plans will be enrolled in a Medicare Advantage plan rated 4 Stars or better next year. "Our improved performance compared to before the pandemic is due to delivering on our ongoing commitment to enhancing consumers' h